Home >> CAP TODAY Webinars On-Demand >> Rapid Lung NGS is enabling clinicians and reducing biomarker testing costs

Rapid Lung NGS is enabling clinicians and reducing biomarker testing costs

image_pdfCreate PDF

Dr. Dagogo-Jack

Dr. Ritterhouse

Webinar presenters Lauren Ritterhouse, MD, PhD, Associate Director, Center for Integrated Diagnostics, Massachusetts General Hospital, Assistant Professor, Pathology, Harvard Medical School, and Ibiayi Dagogo-Jack, MD, Thoracic Oncologist, Massachusetts General Hospital, Assistant Professor of Medicine, Harvard Medical School, discuss consolidating NSCLC biomarker testing into a rapid lung NGS program, what the positive implications are for oncologists and for patients with cancer, and how the new consolidated workflow saves time and resources.

CAP TODAY
X